MMP9 and neoplasm: Western blot analysis revealed that melittin significantly reduced the expression levels of MMP2 and MMP9 in a dose-dependent manner, indicating impaired tumor cell movement, consistent with the results from wound-healing and transwell assays (Figure 8A).